658 results on '"Viel Alessandra"'
Search Results
152. Type and frequency of MUTYHvariants in Italian patients with suspected MAP: a retrospective multicenter study
153. An American founder mutation in MLH1
154. Characterization of the Most Frequent MUTYH Mutation C.933+3a>C (Ivs10+3a>C) in the Northeastern Italian Population
155. Integrated analysis of unclassified variants in mismatch repair genes
156. BRCA1 modulates the expression of hnRNPA2B1 and KHSRP
157. Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction
158. Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
159. The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers
160. Prognostic Relevance of MLH1 and MSH2 Mutations in Hereditary Non-Polyposis Colorectal Cancer Patients
161. Selecting for BRCA1 testing using a combination of homogeneous selection criteria and immunohistochemical characteristics of breast cancers
162. Premature senescence is a major response to DNA cross-linking agents in BRCA1-defective cells: implication for tailored treatments of BRCA1 mutation carriers
163. Somatic mosaicism in a patient with Lynch syndrome
164. Risk analysis of colorectal cancer in women with endometrial carcinoma
165. Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer
166. A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy
167. Reply to Jaskowski et al
168. Phenotypic features and genetic characterization of male breast cancer families: identification of two recurrent BRCA2 mutations in north-east of Italy
169. Germ Line Mutations of Mismatch Repair Genes in Hereditary Nonpolyposis Colorectal Cancer Patients with Small Bowel Cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study
170. Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features
171. Prevalence ofBRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectableBRCA1 andBRCA2 point mutations
172. Stability of BAT26 in tumours of hereditary nonpolyposis colorectal cancer patients with MSH2 intragenic deletion
173. Familial breast cancer: characteristics and outcome of BRCA 1–2 positive and negative cases
174. MUC Gene Abnormalities in Sporadic and Hereditary Mucinous Colon Cancers with Microsatellite Instability
175. Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations
176. The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy
177. Prevalence of the Y165C, G382D and 1395delGGA germline mutations of theMYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas
178. Different molecular mechanisms underlie genomic deletions in theMLH1 Gene
179. Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer
180. Microsatellite Instability in Colorectal Cancer: Prognostic, Predictive or Both?
181. Microsatellite Instability and High Content of Activated Cytotoxic Lymphocytes Identify Colon Cancer Patients with a Favorable Prognosis
182. Four novelMSH2 andMLH1 frameshift mutations and occurrence of a breast cancer phenocopy in hereditary nonpolyposis colorectal cancer
183. Clinical and biologic heterogeneity of hereditary nonpolyposis colorectal cancer
184. Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer
185. Problems in the identification of hereditary nonpolyposis colorectal cancer in two families with late development of full-blown clinical spectrum
186. Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts
187. MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events.
188. Splice variant lacking the transactivation domain of theBRCA2 gene and mutations in the splice acceptor site of intron 2
189. Assessment of pathogenicity criteria for constitutional missense mutations of the hereditary nonpolyposis colorectal cancer genes MLH1 and MSH2
190. BRCA1 andBRCA2 genes: Role in hereditary breast and ovarian cancer in Italy
191. Low incidence ofBRCA1 mutations among Italian families with breast and ovarian cancer
192. Small bowel carcinoma in hereditary nonpolyposis colorectal cancer
193. MLH1 and MSH2 constitutinal mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer
194. Hereditary Nonpolyposis Colorectal Cancer: An Approach to the Selection of Candidates to Genetic TestingBased on Clinical and MolecularCharacteristics
195. Recommendations for the Molecular Diagnosis of Familial Adenomatous Polyposis
196. Survival analysis in families affected by hereditary non-polyposis colorectal cancer
197. Characterization ofMSH2 andMLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer
198. Hereditary nonpolyposis colorectal cancer: Review of clinical, molecular genetics, and counseling aspects
199. Molecular mechanisms possibly affecting WT1 function in human ovarian tumors
200. P-Glycoprotein but not Topoisomerase II and Glutathione-S-Transferase-Pi Accounts for Enhanced Intracellular Drug-Resistance in LoVo MDR Human Cell Lines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.